Joshi Aditya, Griego David J, Gawey Lauren, Ghanshani Raveena, Tran Khiem A, Hsiao Jennifer L, Shi Vivian Y
Department of Dermatology, University of Washington School of Medicine, Seattle, WA, USA.
Creighton University School of Medicine, Phoenix, AZ, USA.
Skin Appendage Disord. 2025 May 8:1-16. doi: 10.1159/000545767.
Hyperhidrosis is a chronic dermatologic condition that significantly impacts quality of life. While research has expanded in recent years, bibliometric analyses exploring publication trends remain limited. This study examined the 100 most-cited articles from 2015 to 2025 to assess research priorities.
A Scopus search was conducted on January 2, 2025, using the terms "hyperhidrosis", "primary hyperhidrosis", "secondary hyperhidrosis", and "excessive sweating". Non-English, abstract-only, and non-hyperhidrosis focused articles were excluded. Two reviewers screened and identified the 100 most-cited publications. Data were analyzed for publication year, authorship, country, study design, journal, and topic focus. The Oxford Centre for Evidence-Based Medicine Level of Evidence (LoE) framework was used to assess study quality.
The majority (76%) of highly cited articles were published between 2015 and 2019. Randomized controlled trials (20%), cohort studies (18%), and case-control studies (16%) were the most common study types. Using LoE assessment, 33% of studies were level 1 (high-quality evidence). Research on treatments (55%) dominated, followed by quality of life (12%) and outcome measures (11%). The USA led in publication output.
This bibliometric analysis identifies evolving research priorities toward minimally invasive treatments and patient-centered outcomes, providing direction for future research and improvements in clinical practice.
多汗症是一种慢性皮肤病,会对生活质量产生重大影响。尽管近年来研究有所扩展,但探索出版物趋势的文献计量分析仍然有限。本研究检查了2015年至2025年被引用次数最多的100篇文章,以评估研究重点。
于2025年1月2日在Scopus数据库中进行检索,使用的检索词为“多汗症”“原发性多汗症”“继发性多汗症”和“多汗”。排除非英文、仅有摘要以及非聚焦于多汗症的文章。两名评审员筛选并确定了被引用次数最多的100篇出版物。对数据进行分析,包括出版年份、作者、国家、研究设计、期刊和主题重点。使用牛津循证医学中心证据水平(LoE)框架评估研究质量。
大多数(76%)被高度引用的文章发表于2015年至2019年之间。随机对照试验(20%)、队列研究(18%)和病例对照研究(16%)是最常见的研究类型。使用LoE评估,33%的研究为1级(高质量证据)。关于治疗的研究(55%)占主导,其次是生活质量(12%)和结局指标(11%)。美国在出版物产出方面领先。
这项文献计量分析确定了朝着微创治疗和以患者为中心的结局发展的不断演变的研究重点,为未来研究和临床实践的改进提供了方向。